Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

How Sports Stars and Drugs Keep Getting Reinvented
Reinvention is everywhere. Products get updated, industries change course, and ideas we once treated as finished suddenly come back in a new form. Something that felt permanent five years ago can look completely different today, redesigned for a new audience or a new moment. read more
An Interview With Franco Negron
Simtra’s capability to support high-volume injectables and lower-volume modalities provides balanced expertise across the sterile injectables landscape. read more
Rethinking the Architecture of Adverse Event Processing
Deploying AI agents to handle data collection, coding, medical review, and quality-checking makes signal management autonomous at the processing stage. read more
Building Resilient Pharma Supply Chains to Strengthen Patient Healthcare
Continuity of care is generally defined in terms of a patient’s ongoing contact with a clinical team and how smoothly their care progresses between providers. Often overlooked is the pharma supply chain and its role in ensuring this continuity. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Cambrex Breaks Ground on $120M Charles City Expansion
Thursday, November 05, 2026
Cambrex has broken ground on a $120 million expansion at its Charles City, Iowa facility. The project will add 160,000 liters of manufacturing ... read more
Alcami Promotes Robert Tragas to VP, Laboratory Services
Thursday, November 05, 2026
Alcami has promoted Robert Tragas to Vice President, Laboratory Services. In his expanded role, Tragas will lead laboratory operations across the CDMO... read more
Samsung Biologics Earns 'Negligible Risk' ESG Rating
Thursday, November 05, 2026
Samsung Biologics has achieved a 'Negligible Risk' rating in the latest Morningstar Sustainalytics ESG Risk Ratings assessment. The CDMO received an ... read more
Pyramid Pharma Services Adds 13th Commercial Product
Thursday, November 05, 2026
Pyramid Pharma Services has expanded a partnership with a longstanding biopharmaceutical customer to manufacture its 13th commercial product: a ... read more
Lonza to Acquire Merck KGaA's US CDMO Sites
Tuesday, November 03, 2026
Lonza has signed a definitive agreement to acquire five CDMO manufacturing sites in the US from Merck KGaA, Darmstadt, Germany, at a total enterprise ... read more